# To Evaluate the Effect of AZD1722 on the Pharmacokinetics of Oral Midazolam in Healthy Volunteers

> **NCT02140268** · PHASE1 · COMPLETED · sponsor: **Ardelyx** · enrollment: 65 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Midazolam
- **DRUG:** AZD1722
- **DRUG:** AZD1722 and Midazolam

## Key facts

- **NCT ID:** NCT02140268
- **Lead sponsor:** Ardelyx
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2015-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02140268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02140268, "To Evaluate the Effect of AZD1722 on the Pharmacokinetics of Oral Midazolam in Healthy Volunteers". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02140268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*